Canadian Medical Center Net Profit Drops 27% in Nine Months

Riyadh, Saudi Arabia — Canadian Medical Center Co. posted a nine-month net profit of 8.55 million SAR for the period ending September 30, 2026, down 27.3% from 11.76 million SAR in the same period a year earlier. Revenue grew 8.7% to 113.09 million SAR, but margin erosion and rising credit loss provisions squeezed earnings sharply.

The result reveals a widening gap between top-line growth and bottom-line delivery. New projects lifted revenue, yet those same projects carried thinner margins. Meanwhile, additional allowances for expected credit losses on trade receivables added pressure across both the quarter and the nine-month period.

Quarterly Performance Deteriorates

The third quarter alone showed steeper damage. Revenue fell 12.7% year-on-year to 36.38 million SAR, while net profit attributable to shareholders collapsed 42.2% to 2.02 million SAR. Sequentially, the picture was no better — revenue slipped 5.9% from the prior quarter, and net profit dropped 42.4% from 3.5 million SAR.

Operational profit fell hardest. At 3.13 million SAR, it dropped 52.2% year-on-year and 31.6% from the prior quarter. Gross profit declined 19.9% year-on-year to 10.11 million SAR, signaling that cost pressures hit before overhead was even counted. Total shareholders’ equity edged down 1% year-on-year to 96.17 million SAR. Earnings per share for the nine-month period stood at 0.11 SAR, against 0.15 SAR a year earlier.

Key Drivers

• NEOM project revenue fell as certain projects were suspended, reducing business volume in both the quarter and the nine-month period.
• The National Guard project was suspended, cutting a significant revenue stream in the current quarter.
• A non-recurring purchase order of 3.5 million SAR recorded in the prior-year quarter did not repeat, inflating the year-on-year revenue gap.
• New project launches drove nine-month revenue up 9%, but those projects carried lower profit margins than existing operations.
• Expected credit loss allowances on trade receivables rose, increasing expenses and suppressing net profit in both the quarter and the period.
• Investment portfolio losses narrowed to 243 thousand SAR from 2.34 million SAR in the prior-year quarter, partially offsetting the revenue and provision headwinds.

What This Means for Investors

• Revenue growth is real but hollow — a 9% top-line gain produced a 27% profit decline, meaning Canadian Medical Center is growing into lower-margin work.
• Project concentration risk is visible. Two suspended projects — NEOM and the National Guard — drove most of the quarterly damage. Investors should watch for contract reinstatement or replacement.
• Rising credit loss provisions suggest receivables quality is deteriorating. If collections worsen, further earnings pressure is likely in the fourth quarter.
• The external auditor issued an unmodified conclusion with no qualifications, so the numbers are clean — but the underlying business trends still warrant close monitoring.

Latest Saudi Arabia investor news and earnings updates

Saudi capital markets coverage and listed company analysis

THE SAUDI STANDARD’S VIEW: CANADIAN MEDICAL CENTER’S PROFIT COLLAPSE EXPOSES THE COST OF GROWTH WITHOUT DISCIPLINE

Canadian Medical Center’s nine-month results present a cautionary lesson for investors in Saudi Arabia’s healthcare services sector: revenue expansion that is not anchored in margin discipline destroys shareholder value. With net profit down more than a quarter while the top line advanced, the company has entered a phase where growth itself has become a liability — a dynamic that demands careful scrutiny from any investor considering exposure to this stock.

• MARGIN DILUTION IS THE CENTRAL PROBLEM

When new project wins consistently carry thinner margins than a company’s existing book of business, every new contract signed worsens the earnings profile. Canadian Medical Center’s gross profit fell nearly 20% year-on-year in the third quarter even as the company continued to onboard work, confirming that cost pressures are structural, not seasonal. Until management demonstrates a pathway to higher-quality contract selection, top-line growth should be treated as a warning signal rather than a positive indicator.

• PROJECT CONCENTRATION IS A MATERIAL RISK

The simultaneous suspension of both the NEOM and National Guard contracts in a single quarter exposed a vulnerability that diversified revenue streams are designed to prevent. When two engagements can account for the majority of a quarter’s earnings deterioration, the business model carries a fragility that is not reflected in headline revenue figures. Investors should demand visible evidence of contract pipeline depth and client diversification before assigning a premium to this business.

• RECEIVABLES QUALITY WARRANTS CLOSE MONITORING

Rising allowances for expected credit losses signal that the quality of revenue already recognized may not fully translate into cash collected. In a healthcare services business operating across government and mega-project clients, receivables cycles can stretch significantly, compounding pressure on working capital and free cash flow. If collections performance does not improve in the fourth quarter, additional provisions could further erode an already diminished earnings base.

• EQUITY STABILITY PROVIDES A FLOOR, NOT A CATALYST

Shareholders’ equity holding near 96 million SAR with only marginal year-on-year erosion indicates the balance sheet has not yet been structurally impaired, and the clean audit conclusion confirms the reported figures are reliable. However, balance sheet stability in the absence of earnings recovery is a defensive characteristic, not an investment thesis. The company needs to demonstrate operational improvement before equity value can serve as more than a downside buffer.

Saudi Arabia’s Vision 2030 is generating unprecedented demand for healthcare infrastructure and services, particularly across giga-projects and expanded government health mandates — an environment that should, in principle, benefit operators of Canadian Medical Center’s profile. Yet the ability to capture that opportunity profitably depends on contract selectivity, receivables management, and operational efficiency that the current results do not yet demonstrate. For this company to become a credible beneficiary of the Kingdom’s healthcare transformation, management must shift focus from revenue volume to sustainable margin delivery — the standard that long-term investors in Saudi Arabia’s growth story will rightly apply.